跳至主要内容
临床试验/NL-OMON22953
NL-OMON22953已完成不适用

Transmural Care for Prostate cancer

Initiator: Catharina Wilhelmina Hospital (CWZ)NijmegenPrimary Sponsor/Performer: Radboud University Nijmegen Medical centerOther performers: CWZ in Nijmegen, Maashospital Pantein in Boxmeer0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Healthy men who consider PSA testing.
  • 2. Men who had prostatectomy for localized prostate cancer

排除标准

  • Insufficient knowledge of the Dutch language.

研究者

发起方
Initiator: Catharina Wilhelmina Hospital (CWZ)NijmegenPrimary Sponsor/Performer: Radboud University Nijmegen Medical centerOther performers: CWZ in Nijmegen, Maashospital Pantein in Boxmeer

相似试验

进行中(未招募)
1 期
Response evaluation with 68Ga-PSMA PET of metastatic prostate cancer castration resistant patients in treatment with 223RaCl2Patients mCRPC eligible to treatment with 223RaCl2MedDRA version: 21.1Level: PTClassification code 10036909Term: Prostate cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10005993Term: Bone metastasesSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.1Level: LLTClassification code 10036223Term: Positron emission tomographySystem Organ Class: 100000004848MedDRA version: 21.1Level: PTClassification code 10062904Term: Hormone-refractory prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2017-001395-38-ITAZIENDA USL DELLA VALLE D'AOSTA50
已完成
1 期
Radionuclide therapy using Lutetium-177 prostate specific membrane antigen (PSMA): a pilot study in men with castrate-resistant prostate cancer (LuPSMA trial)Cancer - ProstateProstate Cancer
ACTRN12615000912583Peter MacCallum Cancer Centre30
尚未招募
Unknown
PRO-Health – A prostate cancer specific healthy eating and exercise programProstate cancer
ACTRN12624000874516Deakin University50
招募中
1 期
Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers (THUNDER): A Two-part Phase 2/3 TrialProstate cancer
CTIS2022-501551-90-00Gasthuiszusters Antwerpen493
招募中
不适用
Evaluation of information provision and treatment decision making for men with early-stage prostate cancer.Prostate cancer, prostaatkanker
NL-OMON22128Tilburg University, St. Elisabeth Hospital400